We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Medica 2024 Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Lifotronic Demonstrates Latest Medical Innovations in Disease Diagnostics

By LabMedica International staff writers
Posted on 06 Feb 2024

Lifotronic (Shenzhen, China) is demonstrating its latest medical innovations, including its CLIA, HPLC, CBC, and POCT solutions, at Medlab Middle East 2024.

Lifotronic is presenting a comprehensive range of solutions for large, medium, and small-sized laboratories to a global audience of experts and scholars at the show. Lifotronic’s eCL8000, dubbed the king of emergency, is one of the featured technology products at the exhibition. eCL 8000 is an 86 T/H fully automated analyzer based on the most advanced Electro-chemiluminescence Immunoassay (ECLIA). More than 90 parameters are available, covering thyroid, fertility, tumor, cardiac, inflammation, bone metabolism markers, etc. At Medlab Middle East 2024, Lifotronic is introducing its latest product, the eCL9000 electro-chemiluminescence analyzer which is designed especially for large labs, hospitals, and chain labs. It can perform 300 tests per hour at a constant speed, meeting the high demand of more than 100 samples per day. It also allows end users to easily conduct immunoassay tests. With a super long walkaway time of 5.5 hours, it frees up the operator’s time, improves work efficiency, and creates a more relaxed and flexible work environment.


Image: The latest CLIA, HPLC, CBC and POCT solutions showcased at Medlab Middle East 2024 (Photo courtesy of Lifotronic)
Image: The latest CLIA, HPLC, CBC and POCT solutions showcased at Medlab Middle East 2024 (Photo courtesy of Lifotronic)

Lifotronic is also showcasing its latest H100 high-pressure liquid chromatography analyzer which has a test speed of 96s/T. Convenient, fast, and accurate, it also has a one-click switch function for HbA1c and thalassemia modes. H100 can greatly improve the analysis process and achieve the ideal balance of quality, efficiency, and cost. In addition, Lifotronic is highlighting the AC310 and AC610 hematology analyzers which are widely recognized for their stable performance. These analyzers not only provide accurate and reliable clinical data for doctors but also offer patients a higher level of medical services. The AC630 hematology analyzer is the latest addition to the hematology analyzer series and its fully automated operation significantly improves the laboratory’s operational efficiency, as well as brings greater convenience to the operator. Lifotronic is also showcasing its complete solution for POCT using fluorescence immunochromatography and colloidal gold rapid detection. The POCT fluorescence immunochromatography analyzer offers several test parameters, is easy to carry, and enables fast detection. Its single-use cartridge design can satisfy the needs of primary healthcare facilities and small to medium-sized labs with low sample volumes.

Related Links:
Lifotronic


New
Gold Member
ANA & ENA Screening Assays
ANA and ENA Assays
New
Gold Member
Syphilis Screening Test
VDRL Antigen MR
New
Electroporation System
Gibco CTS Xenon
New
Strep Pneumoniae Rapid Test
Strep Pneumoniae (6503 – 6573)

Latest Medlab 2024 News

Anbio Biotechnology Presents Point-Of-Care IVD Solutions

77 Elektronika Showcases Latest Developments in Urinalysis

BioVendor Group Unveils Latest Innovations in Immunodiagnostics and Molecular Diagnostics